Papi, A <br/><br/>
Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells.  [electronic resource] 

 -  Cell death and differentiation  Jul 2012 
 - 1208-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5403 
<br/><br/><label>Standard No.: </label>10.1038/cdd.2011.207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Female<br/>Humans<br/>Inflammation--metabolism<br/>Interleukin-6--metabolism<br/>NF-kappa B--metabolism<br/>Neoplastic Stem Cells--cytology<br/>PPAR gamma--agonists<br/>Phenanthrenes--chemistry<br/>Pioglitazone<br/>Pyrimidines--pharmacology<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Receptors, Retinoic Acid--agonists<br/>Retinoid X Receptors--agonists<br/>Thiazolidinediones--chemistry<br/>Tretinoin--chemistry